Baicalin regulates cAMP-PKA-NF-κB/CREB pathway to improve inflammatory response in human microglial cells, indicating potential in ischemic stroke treatment.

https://pubmed.ncbi.nlm.nih.gov/38114182

Baicalin improves inflammatory response in human microglial cells by regulating the cAMP-PKA-NF-κB/CREB pathway, suggesting its potential in treating ischemic stroke.